In response to low doses of ultraviolet (U.V.) radiation, cells undergo a G2 delay. In this study we have shown that the G2 delay results in the accumulation of inactive forms of cyclin B1/cdc2 and both the G2 and mitotic complexes of cyclin A/cdk. This appears to be through a block in the cdc25-dependent activation of these complexes. The expression and localisation of cyclin A and cyclin B1/cdk complexes are similar in U.V.-induced G2 delay and normal early G2 phase cells. Cdc25B and cdc25C also accumulate to normal G2 levels in U.V. irradiated cells, but the mitotic phosphorylation associated with increased activity of both cdc25B and cdc25C is absent. The cdc25B accumulates in the nucleus of U.V. irradiated cells and in normal G2 phase cells. Thus the block in cyclin B/cdc2 activation is in part due to the physical separation of cyclin B/cdc2, localised in the cytoplasm, from the cdc25B and cdc25C phosphatases localised in the nucleus. The data positions the U.V.-induced G2 checkpoint at either the S/G2 transition or early G2 phase, prior to the activation of cyclin A/cdk2.
Introduction
Progression through the cell cycle is regulated by the ordered activation of cyclin dependent kinases (cdks). In yeast, a single cdk, cdc2/CDC28, associates with multiple cyclin partners to regulate both the START and G2/M checkpoints, whereas in higher eukaryotes, a large family of cdks have so far been identi®ed, each of which appears to regulate discrete cell cycle functions (Meyerson et al., 1992; van den Heuvel and Harlow, 1993) . The best characterised in terms of function and regulation is cyclin B/cdc2, the prototypic cyclin/cdk. This complex was ®rst puri®ed from Xenopus eggs as maturation promoting factor (MPF), which was the only factor required to initiate mitosis when injected into prophase arrested frog oocytes (Lohka et al., 1988; Gautier et al., 1988) . The histone kinase activity of cyclin B/cdc2 is regulated through a complex series of protein associations, phosphorylations and dephosphorylations. Cyclin B is synthesised during S and G2 phases, and immediately binds to the catalytically inactive cdc2 monomer in the cytoplasm. Upon association with cyclin B, the cdc2 subunit undergoes a series of phosphorylations. The phosphorylation of Thr 161 is catalysed by CAK (cdk activating kinase), and is essential for the catalytic activity of cdc2, whereas phosphorylation of Thr14 and Tyr15 is inhibitory, and catalysed by a member of the wee1/ mik1 family of kinases (Morgan, 1995) . The latently active form of cyclin B/cdc2 is maintained in the cytoplasm until prophase, when the majority is translocated into the nucleus (Pines and Hunter, 1991; Bailly et al., 1992) . At the same time, the inhibitory Thr14 and Tyr15 phosphates are removed by a member of the cdc25 family of dual speci®city phosphatases, and fully active cyclin B/cdc2 is able to perform its many mitotic functions.
In yeast only a single form of cdc25 exists, but in mammalian systems three isoforms have been identi®ed (Gabrielli, 1994) . Cdc25A has been demonstrated to regulate progression into S phase, while both cdc25B and cdc25C have roles in the G2/M transition (Millar et al., 1991; Jinno et al., 1994; Gabrielli et al., 1996) . The activity of cdc25 is regulated at both a translational and post-translational level. Cdc25C is expressed at a constant level throughout the cell cycle, while the expression of cdc25A and cdc25B has been demonstrated to be cell cycle dependent in some cell lines (Jinno et al., 1994; Gabrielli et al., 1996) . The activity of both cdc25A and cdc25C is further modulated by phosphorylation (Homan et al., 1993; Homann et al., 1994) .
A further level of regulation of the cyclin/cdks has been identi®ed, through the binding of low molecular weight protein inhibitors of these complexes. Two families of these proteins have been identi®ed, the p21 Cip1 family including p21
Cip1
, p27 Kip1 and p57 Kip2 , and the p16 CDKN2A family including p16 CDKN2A , p15 CDKN2B , p18 CDKN2C and p19 CDKN2D (Sherr and Roberts, 1995) . The members of the p21 family bind to a wide range of cyclin/cdks, whereas the p16 family proteins have a much more restricted speci®city, binding only to cyclin D/cdk4 and cdk6 (Sherr and Roberts, 1995) . These proteins appear to respond to extracellular in¯uences to produce cell cycle delays, for example, increased expression of p21 is induced by exposure to ionising radiation and is involved in a G1 delay (Dulic et al., 1994) , while p16 induced by irradiation with ultraviolet (U.V.) light is correlated with a G2 delay (Wang et al., 1996) .
Exposure of cells to low doses of U.V. light produces delays in G1, S and G2/M phases of the cell cycle, depending on the dose and cell type used (Lu and Lane, 1993; Wang and Ellem, 1994; Barker et al., 1995; Petrocelli et al., 1996; Poon et al., 1996) . A role for p53-induced expression of p21, and the redistribution of p27 among G1 and S phase cyclin/cdks in U.V.-induced G1 and possibly S phase delays has been demonstrated (Lu and Lane, 1993; Barker et al., 1995; Poon et al., 1995; Petrocelli et al., 1996) . The inhibitory tyrosine phosphorylation of cdk4 has also been implicated in the U.V.-induced G1 delay (Terada et al., 1995) . The U.V.-induced G2 delay is independent of p53 function (Herzinger et al., 1995; Wang et al., 1996) , and involves a block in the cdc25-dependent activation of cyclin B/cdc2 (Herzinger et al., 1995; Poon et al., 1996) . In this report we show that the U.V.-induced G2 delay is mediated through a block in the cdc25-dependent activation of cyclin B1/cdc2, cyclin A/cdk2 and cyclin A/cdc2, and that this block occurs at the S/G2 transition or early G2. The block in cdc25 function is not due to a reduction in the levels of either cdc25B or cdc25C proteins, but rather to the nuclear accumulation of cdc25B, and the inhibition of mitotic phosphorylation and activation of both cdc25B and cdc25C.
Results
Activation and nuclear translocation of the cyclin B1/ cdc2 complex is blocked by U.V. irradiation
In response to low doses of U.V.C., HeLa cells are delayed in S and G2/M phases of the cell cycle (Wang and Ellem, 1994) . Irradiation of an asynchronously growing population of the melanoma cell line A2058 also resulted in an accumulation of cells in G2/M (Figure 1a) . No signi®cant accumulation or delay of cells in S phase was observed with this cell line, which was in contrast to HeLa cells irradiated under identical conditions. Following a delay of up to 20 h in G2/M, the cells recommenced progression through the cell cycle at 36 h after irradiation, which can be seen by a sharp increase in G1 and concomitant decrease in G2/ M phase cells at this time point (Figure 1b) . We have investigated further the nature of the G2/M delay in HeLa and A2058 cell lines.
The expression and activity of cyclin B1/cdc2, a key regulator of entry into mitosis, was analysed by immunoblotting and assaying the immunoprecipitated kinase from lysates of asynchronously growing HeLa cells (AS) which are 60% G1 phase cells, U.V. irradiated G2 delayed cells (U.V.), and late S/G2 (G2) and G2/M (M) cells from a thymidine synchrony (see Materials and methods). Immunoblotting with an anti-cyclin B1 antibody showed that cyclin B1 accumulated to normal G2 levels in the U.V. irradiated G2 delayed cells ( Figure  2a ), but only the G2/M phase cyclin B1/cdc2 was catalytically active (Figure 2b ). Analysis of samples of similarly treated populations of A2058 cells again showed normal G2 phase accumulation of cyclin B1 and block in activation of the cyclin B1/cdc2 complex in the U.V. irradiated G2 delayed cells as was seen in HeLa (Figure 2c and d) . Indirect immuno¯uorescence showed that the U.V. irradiated G2 delayed HeLa cells accumulated high levels of cyclin B1 in the cytoplasm, as in normal G2 phase cells (Pines and Hunter, 1991; Bailly et al., 1992) , although due to the delay in transit through G2 in the irradiated sample up to 60% of the population showed bright cytoplasmic staining for cyclin B1, compared to 520% of a normal asynchronous culture (Figure 2e and f) .
Analysis of the cyclin B1/cdc2 complexes in U.V. irradiated G2 delayed HeLa cells, showed that cdc2 was complexed with cyclin B1 to the same extent as in normal S/G2 cells, and that the cdc2 was predominantly the slower migrating, Thr14 Tyr15 phosphorylated form, which was converted to the faster migrating, dephosphorylated, active form at mitosis (Figure 3a ). This was con®rmed by phosphotyrosine immunoblotting of the same cyclin B1 immunoprecipitates, which showed high levels of phosphotyrosine on cdc2 in both U.V. irradiated G2 delayed and normal S/G2 cyclin B1/cdc2 complexes (Figure 3b ). This suggested that the G2 delay was due to a block in the cdc25-dependent activation of the cyclin B1/cdc2 complex. The recovery of the histone kinase activity of cyclin B1 immunoprecipitates from G2 delayed HeLa cells using bacterially expressed cdc25B further supported this model (Figure 3c ). The inhibition of the cyclin B1/cdc2 activation by sodium vanadate proved that the increased histone kinase activity was due to the action of the recombinant cdc25B.
Activation of cyclin A/cdk complexes is blocked by U.V. irradiation
Analysis of cyclin A expression showed that the level of cyclin A in the U.V. irradiated G2 delayed cells was lower than in the S/G2 cells in both HeLa and A2058 cultures (Figure 4a and c), but this simply re¯ected the lower degree of synchrony obtained with U.V. irradiation of an asynchronous culture compared to cultures synchronised by a thymidine block. The reduced level of cyclin A in the G2/M samples is in accordance with the demonstrated destruction of cyclin A during mitosis prior to the destruction of cyclin B in anaphase (Minshull et al., 1990; Pines and Hunter, 1990) . Assay of the histone kinase activity of cyclin A immunoprecipitates from these samples showed that the level in the U.V. irradiated G2 delayed samples was equivalent to the S/G2 synchronised cells, and was always less than that of G2/M cells (Figure 4b and d) . The dierence in the levels of cyclin A associated histone kinase activity in the S/G2 samples of HeLa and A2058 cells was due to the relative levels of cyclin A/cdk2 activity in S phase in the two cell lines. HeLa cells have been shown to have high levels of S phase cyclin A/cdk2 activity, and only a relatively small increase in the cyclin A/cdk2 histone kinase activity in G2 and mitosis (Pines and Hunter, 1990; . In A2058 cells, a comparatively low level of cyclin A associated histone kinase activity was seen throughout S phase, with an abrupt increase in cyclin A associated kinase activity detected as the cells progressed from S into G2 phase, preceding the activation of cyclin B1/cdc2 (Figure 4e ). The major component of the increased cyclin A associated histone kinase activity detected in G2/M samples was due to the activation of cyclin A/cdk2, as anti-cyclin A and anti-cdk2 immunoprecipitate histone kinase assays from both HeLa (Figure 4f ) and A2058 (data not shown) were essentially identical, and an increase in anti-cdc2 immunoprecipitate histone kinase activity was only seen in G2/M phase cells (Figure 4g ). This indicated that the activation of both cyclin A/cdk2 in G2, and cyclin A/cdc2 at G2/M, was blocked in U.V. irradiated G2 delayed cells.
Work from other laboratories has shown that the cdk inhibitor proteins p21 and p27 have a role in the U.V.-induced G1 cell cycle delay, through the binding and inhibition of cyclin D/cdk4 and cyclin A/cdk2 complexes (Poon et al., 1995 Petrocelli et al., 1996) . Cdk2 immunoprecipitates from asynchronous control and U.V. irradiated G2 delayed HeLa and A2058 cells revealed that HeLa cdk2 was not associated with p21 and that the level of p21 associated with cdk2 in A2058 cells decreased following U.V. exposure ( Figure 5a ). This was in contrast to neonatal foreskin ®broblasts (NFF), where the level of p21 associated with cdk2 increased dramatically following U.V. exposure. The level of p21 associated with cdk2 re¯ected the changes in total p21 levels (data not shown). P27 was also found to be associated with cdk2 in all three cell lines, although the levels decreased in the U.V. irradiated G2 delayed HeLa and A2058 samples compared with the asynchronous controls ( Figure 5a ). Decreased levels of p27 associated with cdk2 were also detected in S/G2 and G2/M HeLa cell samples compared to the Cyclin B1/cdc2 is maintained in the tyrosine phosphorylated form in G2 delayed cells. Cyclin B1 immunoprecipitates from lysates of the indicated HeLa cell samples (as in Figure 2 ) were either immunoblotted with an anti-cdc2 monoclonal antibody (a) or anti-phosphotyrosine monoclonal antibody (b). (c) Cyclin B1 immunoprecipitates from U.V. irradiated G2 delayed HeLa cells were incubated with or without puri®ed bacterially expressed GST-cdc25B and sodium vanadate, then assayed for histone H1 kinase activity predominantly G1 phase asynchronous samples (data not shown), suggesting that the decreased association in the U.V. irradiated cells simply re¯ected a decreased association normally occurring in G2 phase, rather than a U.V.-induced eect. Cyclin A immunoprecipitates from similar samples did not contain detectible levels of either p21 or p27, suggesting that the p21 and p27 detected was associated with other cyclin/cdk2 complexes. No p21 or p27 was found in cyclin B1 immunoprecipitates from similar HeLa and A2058 samples. The lack of p21 or p27 involvement in the U.V.-induced block in cyclin A/cdk2 activation in G2 indicated that this complex was inhibited in some other manner. The inactive cyclin A/cdk2 complex in late S/G2 phase cells has been demonstrated to be phosphorylated on Tyr15, and that this phosphorylation is lost on activation of the complex in G2 . Incubation of cyclin A immunoprecipitates from U.V. irradiated G2 delayed, S/G2 and G2/M HeLa cells with recombinant cdc25B resulted in the activation of the cyclin A complexes to similar maximal levels, and the activation was inhibited by addition of sodium vanadate (Figure 5b ). Recombinant cdc25B was also found to activate cyclin A immunoprecipitates from similar A2058 cell samples, and similar results were obtained using cdk2 immunoprecipitates from both cell lines (data not shown). Immunoblotting of the cyclin A immunoprecipitates for cdk2 revealed similar levels of cdk2 in each sample, and cyclin A associated exclusively with the faster migrating form of cdk2, corresponding to the Thr160 phosphorylated form of cdk2 . This again pointed to a U.V.-induced block in the cdc25-dependent progression through G2 into mitosis.
Expression of the mitotic cdc25s is unaected in U.V.-induced G2 delay
We have demonstrated that the cdc25-dependent activation of both cyclin A/cdk2 and cyclin B1/cdc2 was blocked in the U.V. irradiated G2 delayed cells. Therefore we assessed the expression of the two cdc25 isoforms which are known to have a role in regulating mitosis, cdc25B and cdc25C. The level of cdc25C was found to be unchanged throughout the normal cell cycle and G2/M HeLa cell samples were incubated with recombinant GST-cdc25B either in the presence or absence of sodium vanadate, and either assayed for histone H1 kinase or immunoblotted for cdk2. The level of H1 phosphorylation was quantitated by phosphorimaging, and the relative levels are shown in both HeLa and A2058 cells, and this was not aected in G2 delayed cells (Figure 6a) . A low level of the slower migrating, hyperphosphorylated form of cdc25C was detected in the G2/M samples from both cell lines, but was not detected in either U.V. delayed, or synchronised S/G2 samples ( Figure 6a , ®lled arrowhead). The levels of both cdc25B mRNA and protein have been demonstrated to vary through the cell cycle, being maximal at G2/M (Nagata et al., 1991; Gabrielli et al., 1996) . The level of cdc25B mRNA and protein accumulated to nearly S/G2 levels in the U.V. irradiated G2 delayed HeLa and A2058 cells ( Figure  6b, c and d) . Again, the dierences in the levels of cdc25B transcript and protein between the U.V. delayed and synchronised S/G2 cells was due to the relatively higher percentage of G2 phase cells in the synchronised S/G2 compared to U.V. delayed samples. The cdc25B protein in both the S/G2 and U.V. irradiated G2 delayed cells ran as a single band, whereas a slower migrating form of cdc25B was detected in the G2/M phase samples from both HeLa and A2058 cells (Figure 6c and d, ®lled arrowheads).
Activation and cytoplasmic accumulation of cdc25B is blocked in U.V.-induced G2 delay
The slowest migrating form of cdc25B was suspected of being a phosphorylated form of the protein, as it was dicult to detect in cdc25B immunoprecipitates from G2/M phase cells without the inclusion of microcystin, a potent inhibitor of phosphatases PP1 and PP2A, in the lysis buer (unpublished observations). The appearance of the electrophorectically retarded form of cdc25B was previously shown to coincide with the cdc2-dependent increase in microtube nucleation at the centrosome and changes in microtubule dynamics , suggesting that this was the mitotically active form of cdc25B, similar to the hyperphosphorylated form of cdc25C (Homann et al., 1993) . The activity of both cdc25B and cdc25C was assessed by the ability of immunoprecipitated cdc25B and cdc25C to activate a Thr14 and Tyr15 phosphorylated cdc2/cyclin B1 complex (PY15) produced in vitro. The cdc25 antibodies have previously been shown to be speci®c for their respective isoform . The relative cdc25 activity of the immunoprecipitated cdc25 was quantitated by the increased histone H1 kinase activity of the activated PY15 substrate. Immunoprecipitated cdc25B from U.V. irradiated G2 delay, S/G2 and G2/M HeLa cells increased PY15 H1 kinase activity over the preimmune levels (the PY15 substrate possesses a low level of H1 kinase activity), with the G2/M sample showing the largest increase (Figure 7a ). The dierence between the U.V. irradiated G2 and S/G2 samples was due to the lower level of cdc25B in the former (Figure 7a, immunoblot) . The activity of cdc25B in the G2/M samples was less than twice that from S/G2 samples, but this small increase in activity re¯ected the relatively low abundance of the electrophoretically retarded form of cdc25B in these samples. The increased H1 kinase activity was shown to be due to the action of the immunoprecipitated cdc25B, as it was blocked by the inclusion of sodium vanadate in the incubation (Figure 7a) .
Similar immunoprecipitate activity assays were performed for cdc25C. The cdc25C from an asynchronous culture (predominantly G1 phase cells) had little activity towards PY15, whereas both the U.V. irradiated and S/G2 samples contained a low, though reproducible level of activity, and G2/M cdc25C was greater than fourfold more active than cdc25C from either G2 sample (Figure 7b ). The level of immunoprecipitated cdc25C protein did not vary between samples, as seen in the immunoblots of whole cell lysates (Figure 6a) , and again only a very low level of the hyperphosphorylated cdc25C was detected in the G2/M samples, as an indistinct, lower mobility smear (Figure 7b, immunoblot) . The speci®city of the activation assay was demonstrated by the ability of sodium vanadate to inhibit the increase in PY15 H1 kinase activity. The absence of the lower mobility forms of both cdc25B and cdc25C in the U.V. irradiated G2 delayed cells indicated that the mitotic phosphorylation and activation of both cdc25 isoforms was blocked, although both cdc25B and cdc25C from both G2 samples were capable of activating the exogenous PY15 substrate, albeit to a reduced extent.
We had previously demonstrated that the mitotic activity of cdc25B is tightly correlated with its accumulation in the perinuclear region and more broadly in the cytoplasm . Indirect immuno¯uorescent staining of U.V. irradiated G2 delayed HeLa cells showed a striking accumulation of cdc25B staining in the nucleus and negative staining of the nucleoli (Figure 8c ). This had not previously been noted in immunostaining experiments of asynchronous cultures, although closer inspection of these did show a very low percentage of cells with increased nuclear staining suggesting that this may represent a transient nuclear accumulation of cdc25B in early G2 phase. This was con®rmed by indirect immuno¯uorescent staining of synchronised late S/G2 phase HeLa cells which revealed a high level of nuclear cdc25B staining in a majority of cells (Figure 8a ), similar to the U.V. irradiated G2 delayed cells, although a small proportion of the synchronised population cells also showed the cytoplasmic localisation in prophase and mitotic cells, as previously described . The increased nuclear staining in both samples correlated with the elevated levels of cdc25B detected by immunoblotting (Figure 6c and d) , and the speci®city of the staining demonstrated by using antibody solutions preincubated with GST-cdc25B, which reduced the staining to near background (Figure 8b ). Counterstaining with a b-tubulin monoclonal antibody showed the microtubule network to be the normal interphase, basket-like array, with no mitotic increase of microtubule nucleation on the centrosomes or changes in microtubule dynamics were observed.
Discussion
Activation of a G2 checkpoint is a common mechanism by which cells respond to genotoxic stress. However, the response mechanisms leading to the G2 delay dier depending on the agent causing the stress, although they appear to converge at cdc2, resulting in an accumulation of the Tyr15 phosphorylated form of cdc2. Exposure to ionising radiation in S phase inhibits cyclin B mRNA accumulation, while exposure in G2 inhibits cyclin B translation, both of which suppress cyclin B/cdc2 activation at mitosis (Muschel et al., 1991) , whereas cyclin B levels are unaected following exposure to nitrogen mustard, but cyclin A mRNA and protein levels exceed control levels in the G2 delay induced by both ionising radiation and nitrogen mustard (O'Connor et al., 1993; Muschel et al., 1993) . In this study, cyclin B1 accumulated to normal G2 levels, and formed complexes with cdc2 which are maintained as the inactive Tyr15 phosphorylated form in the U.V. induced G2 checkpoint. A U.V.-induced accumulation of Tyr15 phosphorylated cdc2/cyclin B has also been reported in keratinocytes and ®broblasts (Herzinger et al., 1995; Poon et al., 1996) . Our data con®rms these earlier ®ndings, but also shows that the inactive cyclin B12/cdc2 complex is maintained in the cytoplasm as seen in normal G2 phase cells, indicating that not only is the mitotic activation of this complex inhibited, but its translocation from the cytoplasm to the nucleus is also blocked. The translocation of cyclin B1/cdc2 to the nucleus appears to be controlled by phosphorylation of the cytoplasmic retention signal (Pines and Hunter, 1994; Li et al., 1997) , and in Xenopus the nuclear translocation has been demonstrated to be essential for GVBD, a marker of entry into metaphase of meiosis I (Li et al., 1997) . Thus blocking the translocation of cyclin B1/cdc2 to the nucleus can eectively inhibit entry into mitosis. This has been demonstrated in cells overexpressing a non-phosphorylatable Thr14 and Tyr15 mutant of cdc2. These cells have a reduced G2 delay following exposure to ionising radiation (Jin et al., 1996) , but during the G2 delayed, cells had high levels of cytoplasmic cyclin B/cdc2 activity, indicating that the correct localisation of cyclin B/cdc2 activity is essential for mitosis.
We have also found that cyclin A accumulates to levels approaching normal G2 levels in the U.V. irradiated G2 delayed cells, and that the cyclin A/cdk complexes are maintained in an inactive form which can be activated to mitotic levels by cdc25 in vitro. The cyclin A/cdk includes both the large peak of cyclin A/cdk2 normally activated in G2, and the relatively minor peak of cyclin A/cdc2 which is activated as the cells enter mitosis Pagano et al., 1993) . The G2 phase activation of cyclin A/cdk2 is clearly blocked, and our data suggests that the activation of the small pool of cyclin A/cdc2 is also blocked, as the low level of cdc2 H1 kinase activity in the U.V. irradiated G2 delayed cells was equivalent to that in the S/G2 sample. This is in contrast to cells exposed to nitrogen mustard, where cyclin A/cdk2 is active during the G2 delay induced by this agent (O'Connor et al., 1993) . The function of cyclin A/cdk2 activity in G2 and mitosis is still unclear, but there is good experimental evidence suggesting a key role for cyclin A/cdk activity in regulating the timing of cyclin B/cdc2 activation and progression into mitosis (Walker and Maller, 1991; Pagano et al., 1992 Pagano et al., , 1993 .
There is evidence for a role for p53 in a G2/M cell cycle delay (Agarwal et al., 1995) , but the G2 delay investigated in this study is independent of p53 function, as HeLa cells lack a functional p53 protein (Wang et al., 1996) , and the lack of an increase in the level of p21 in the A2058 cells suggests that these cells also lack a U.V.-induced p53 response. By comparison, neonatal ®broblasts displayed a dramatic increase in p53-dependent p21 expression and binding to cdk2, associated with a U.V.-induced G1/S phase delay as described by others (Petrocelli et al., 1996; Poon et al., 1996) . This indicates the presence of a second DNA damage induced checkpoint mechanism, independent of p53, which is activated either by DNA that escapes the p53-dependent mechanism, or which occurs after the G1 checkpoint through which p53 operates. Evidence presented here suggests that this is via a block in the cdc25-dependent activation of both cyclin A/cdk complexes and cyclin B1/cdc2 in G2 are regulated by a cdc25 phosphatase.
Expression of cdc25B and cdc25C was found to be unaected in the U.V. irradiated G2 delayed cells, but the slower migrating forms of both cdc25B and cdc25C were absent in the G2 delayed as well as the normal S/ G2 cells. The mitotic hyperphosphorylation of cdc25C has been associated with an increase in its activity (Homann et al., 1993) , which we have con®rmed in this study, although the levels of hyperphosphorylated cdc25C detected in the G2/M HeLa and A2058 samples were very low. The loss of the hyperphosphorylated form of cdc25C has also been observed in G2 delays in response to both ionising radiation and nitrogen mustard, with the corresponding loss of mitotic activation (O'Connor et al., 1994; Barth et al., 1996) . This is presumably simply a consequence of the block of cyclin B/cdc2 activation, which is proposed to be responsible for the mitotic hyperphosphorylation and activation of cdc25C, via an autoampli®cation mechanism (Homann et al., 1993) . The slower migrating form of cdc25B observed in mitotic samples also appeared to be the result of a mitotic phosphorylation, and was correlated with an increase in its activity. We have found that in vitro phosphorylation of recombinant cdc25B, using mitotic HeLa cell extracts, produced a 4 ± 5-fold increase in cdc25B activity (unpublished data). It is probable that this mitotic activation is also due to an autoampli®cation mechanism similar to that for cdc25C.
However, cdc25B from both G2 delayed and normal S/G2 phase samples had a signi®cant level of activity using a recombinant PY15 substrate in vitro, whereas only a very low level of cdc25C activity was found in these samples. We have also found that the bacterially expressed, unphosphorylated cdc25B is 4fourfold more active than cdc25C, but the hyperphosphorylated forms of the two recombinant proteins have similar levels of activity in vitro (manuscript in preparation), mimicking the in vivo activities of these two enzymes. Thus the block in mitotic activation of cdc25B in the U.V. irradiated G2 delayed and normal early G2 cells, cannot explain the observed block in cyclin A/cdk2 and cyclin B1/cdc2 activation.
A partial explanation may be found in the cellular localisation of the cdc25s and cyclin/cdks. The nuclear accumulation of cdc25B in both the U.V. irradiated and normal S/G2 phase cells was unexpected, although ectopically expressed cdc25B also accumulated in the nucleus of the majority of transfected cells, indicating that cdc25B possesses functional nuclear localisation sequences. The nuclear accumulation of cdc25B in the G2 delayed cells would also contribute to the block in cyclin B1/cdc2 activation, as both cdc25B and cdc25C are now localised in the nucleus, whereas the inactive cyclin B1/cdc2 complex is localised in the cytoplasm of the U.V. irradiated G2 delayed and normal G2 cells, and is thus physically separated from the potentially activating phosphatases. In this respect, the G2 delayed cells appear to be identical to normal early G2 phase cells, but whereas this is only a transitory phase in cells normally progressing through the cell cycle, following U.V. irradiation the cells are held at this point in the cell cycle until a signal for resumption of normal progression through into mitosis is generated. This would presumably include a signal for relocation of cdc25B into the cytoplasm as was previously observed . Separate compartmentation, however, cannot provide an explanation for the lack of activation of the G2 and mitotic cyclin A/cdk complexes in the U.V. irradiated G2 delayed and normal G2 cells, as these complexes are almost exclusively nuclear (Pines and Hunter, 1991; Bailly et al., 1992; Pagano et al., 1992) . Recombinant cdc25B can activate the immunoprecipitated cyclin A/ cdk2 and presumably cyclin A/cdc2, from U.V. irradiated G2 delayed and normal S/G2 cells in vitro, suggesting that some other factor is blocking the cdc25-dependent activation of the cyclin A/cdk, and that factor is lost during the immunoprecipitation of the cyclin A/ cdk2 complex. One possibility is that p95WEE1Hu, which is also localised to the nucleus (McGowan and Russell, 1995) , could maintain the cyclin A/cdk2 in its Tyr15 phosphorylated inactive state. This kinase has been demonstrated to be speci®c for the phosphorylation of Tyr15, and is active throughout the cell cycle except mitosis when its activity is severely reduced (Parker et al., 1995; McGowan and Russell, 1995) . The signal for the resumption of cell cycle progression may be the inactivation of this kinase, which may be sucient to shift the balance to favour the cdc25-dependent activation of cyclin A/cdk2. A triggering role for cyclin A/cdk in the subsequent activation of cyclin B/cdc2 and entry into mitosis has been proposed (Minshull et al, 1990; Lehner and O'Farrell, 1990) .
Alternatively, the delay may be attributed solely to the regulation of cdc25 activity. The identi®cation of a cdc25-dependent pathway in the G2 delay has precedents in both ®ssion yeast and Xenopus systems, where incomplete DNA replication can block the cdc25-dependent activation of mitotic cyclin/cdks (Enoch and Nurse, 1990; Kumagai and Dunphy, 1991; Gabrielli et al., 1992) . In both systems, mitotic levels of cdc25 are present, but the cdc25 is maintained in an inactive form until replication is completed (Izumi et al., 1992; Kovelman and Russell, 1996) . This parallels our ®ndings for cdc25C, where the level of cdc25C protein was unchanged, but only displayed a signi®cant level of activity in G2/M samples. In the U.V. response, DNA replication is completed prior to the G2 delay, demonstrated by an accumulation of cells with 4N DNA content. Therefore the cdc25-dependent G2 delay is presumably invoked by the presence of damaged DNA, and this delay allows for repair of the U.V.-induced DNA damage.
In summary, this study has shown that the G2 phase checkpoint invoked following low dose U.V.C. exposure results in the accumulation of the inactive Tyr15 phosphorylated forms of cdk2/cyclin A, cdc2/ cyclin B1 and presumably cdc2/cyclin A, which eectively blocks progression into mitosis. This block of both cyclin A/cdk and cyclin B1/cdc2 activation puts the U.V.-induced G2 delay at the S/G2 transition or early G2 before the activation of cyclin A/cdk in G2, rather than the G2/M transition. The mechanism of the G2 checkpoint is independent of p53 and p21, and appears to be due to inhibition of the cdc25-dependent dephosphorylation and activation of the mitotic cdk/cyclins. This is in part due to a block in the mitotic hyperphosphorylation and activation of cdc25B and cdc25C, which in the case of cdc25C appears to be essential for its activity. However, normal G2 phase cdc25B retains a signi®cant level of activity, but is blocked from activating cdc2/cyclin B1 due to the separate compartmentation of the cdc25B and cdc2/ cyclin B1. It is unclear as to the mechanism by which active cdc25B is blocked from activating cyclin A/cdk2 and cyclin A/cdc2, both of which are localised to the nucleus with cdc25B in G2.
Materials and methods
Cell culture, synchrony and U.V. treatment HeLa (cervical adenocarcinoma derived) and A2058 (human melanoma) cells were grown in RPMI 1640 medium supplemented with 5 and 10% Serum Supreme (Biowhittaker), respectively, and 0.1 mg/ml streptomycin and 100 U/ml penicillin. Synchronised cells were obtained by seeding 10 cm plates with 1 ± 1.5610 6 cells, then the following day adding 2 or 2.5 mM thymidine to A2058 and HeLa cultures, respectively, for 16 h. The cells were released from the thymidine block by washing three times with prewarmed serum-free RPMI 1640, and replacing this with fresh medium supplemented with 24 mM deoxycytidine and thymidine. S/G2 phase cells were collected 8 h after release, and G2/M cells were collected when 425% cells had a rounded mitotic morphology. The cell cycle stage was determined using¯ow cytometry as previously described . This protocol routinely gave 50 ± 60% synchrony, assessed by¯ow cytometry and cyclin B1 histone kinase assay, respectively (see Figure 4e) . U.V. irradiated G2 delayed cells were obtained by irradiating asynchronously growing cultures with 10 Jm 72 UVC as described previously (Wang and Ellem, 1994) , with the cells collected 18 ± 24 h later, at which time 40 ± 60% of this cell population were in G2/M (see Figure 1b) .
Immunoblotting and immunoprecipitate kinase assays
Equal cell numbers were lysed in NETN (20 mM Tris pH 8.0, 1 mM EDTA, 100 mM NaCl, 0.5% NP-40) supplemented with 300 mM NaCl and 5 mg/ml leupeptin, pepstatin A and aprotinin, and 0.5 mM PMSF, 10 mM NaF and 0.1 mM sodium vanadate. The cleared supernatant was then used for either immunoblotting or immunoprecipitate kinase assay. Immunoblotting for cyclin B1 and cdc25B was performed as described previously , and cyclin A and cdc25C immunoblots were performed in a similar manner. Brie¯y, 20 mg protein was resolved on 10% SDS ± PAGE gels, electrotransferred to nitrocellulose ®lters and probed with either an anity puri®ed anti-cdc25C polyclonal antibody or anti-cyclin A monoclonal antibody (Pharmingen), and detected using ECL (DuPont). For kinase assays, immunoprecipitations were performed from 1 mg of cell lysate. Cyclin B1 immunoprecipitate kinase assays were as described previously , and cyclin A immunoprecipitate kinase assays were performed in a similar manner, using 1 mg anti-cyclin A antibody. Immunoblotting for cyclin B1 associated cdc2, cyclin A associated cdk2, and cdk2 associated p21 and p27, was performed by resolving the immunoprecipitates on 12% SDS ± PAGE gels, and probing the nitrocellulose transfers with either anti-cdc2 (Santa Cruz), anti-phosphotyrosine monoclonal antibodies, anti-cdk2 polyclonal antibody (Santa Cruz), anti-p21 (Calbiochem) or anti-p27 (Transduction Laboratories) monoclonal antibodies, using ECL detection.
Northern blotting
Total RNA was prepared from 10 7 HeLa cells from the indicated cell cycle stage, prepared as described above, using RNA extraction columns (Qiagen). Twenty mg of RNA was run out on a 1% agarose/formaldehyde gel and blotted onto Hybond-N membrane (Amersham). Equivalent lane loading were monitored by the ethidium bromide staining of the ribosomal RNA bands. Blots were hybridised with a 2.2 kb fragment of cdc25B cDNA.
Cdc25 assays
Bacterially expressed GST-cdc25B wild type was prepared as described previously . The bacterial lysates were diluted in NETN supplemented with protease inhibitors (as described above) and 2 mM DTT, then incubated with 300 ml of 50% suspension of glutathione-agarose for 2 h at 48C. The precipitates were washed twice in NETN supplemented with 2 mM DTT, twice with NETN supplemented with 1 M NaCl and 2 mM DTT and once with phosphatase buer (20 mM Tris pH 8.2, 2 mM EDTA, 2 mM DTT, 150 mM NaCl, 0.1% TX-100), and the GST-cdc25B was eluted with 200 ml of phosphatase buer containing 10 mM glutathione, for 1 h at 48C. Thirty ml aliquots of the eluted GST-cdc25B were added to cyclin A or cyclin B1 immunoprecipitates with or without addition of 5 ml of 5 mM sodium vanadate, and incubated for 30 min at 308C, when the reaction was stopped with the addition of 5 ml of 5 mM sodium vanadate. The resultant histone kinase activity of the cyclin immunoprecipitates was then measured as previously described.
For cdc25 immunoprecipitate assays, each cdc25 was immunoprecipitated from 1.5 mg of HeLa cell lysate, prepared as described above and supplemented with 2 mM microcystin and 5 mM DTT. Lysates were precleared by incubating with 30 ml of a 50% suspension of protein ASepharose for 30 min at 48C. The supernatant was then incubated with either anity puri®ed, cdc25B or cdc25C speci®c antibodies bound to 30 ml of 50% suspension of protein A-Sepharose, for 3 h at 48C. The precipitates were washed twice with NETN with 5 mM DTT, then twice with NETN containing 5 mM DTT and 1 M NaCl, and once with phosphatase buer. The activity of the immunoprecipitated cdc25 was assayed by quantitating the increase in activity of a Thr14 and Tyr15 phosphorylated cdc2/cyclin B1 (PY15) produced in vitro. The production of PY15 will be detailed elsewhere (manuscript in preparation). Brie¯y, baculovirus expressed human cyclin B1 GST fusion was bound to glutathione-agarose then incubated in a HeLa cell lysate with the addition of 2 mM ATP, 15 mM MgCl 2 and the cdk inhibitor olomucine (0.1 mM). The agarose bound GST-cyclin B1/cdc2 was washed and cleaved from the GST moiety with thrombin. The released Thr14, Tyr15 and Thr161 phosphorylated cdc2/cyclin B1 was then stored at 7708C until use. Five ml of PY15 substrate was diluted with 15 ml of phosphatase buer and incubated with the immunoprecipitated cdc25 for 30 min at 308C. The reaction was stopped by addition of 5 ml of 5 mM sodium vanadate, and the increase in H1 kinase activity measured as described above.
Immuno¯uorescence studies
Indirect immuno¯uorescent staining for cdc25B, cyclin B1 and b-tubulin were performed as described previously .
